mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered Tumors.
在基因预选择的PIK3CA改变肿瘤队列中，mTORC1驱动的蛋白质翻译与Capivasertib的临床获益相关
期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-24-0113
Sobsey Constance A, Froehlich Bjoern C, Mitsa Georgia, Ibrahim Sahar, Popp Robert, Zahedi Rene P, de Bruin Elza C, Borchers Christoph H, Batist Gerald
